Abstract:Background A variety of imaging techniques can be used to evaluate diffusion characteristics to differentiate malignant and benign pancreatic lesions. The diagnostic performance of diffusion parameters has not been systematic assessed. Purpose We aimed to investigate the diagnostic efficacy of quantitative diffusion-weighted imaging (DWI) for pancreatic lesions. Methods A literature search was conducted using the PubMed, Embase, and Cochrane Library databases for studies from inception to March 30, 2020, which involves the quantitative diagnostic performance of diffusion-weighted imaging (DWI) and intravoxel incoherent motion (IVIM) in the pancreas. Studies were reviewed according to inclusion and exclusion criteria. The quality of articles was evaluated by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUATAS-2). A bivariate random-effects model was used to evaluate pooled sensitivities and specificities. Univariable meta-regression analysis was used to test the effects of factors that contributed to the heterogeneity. Results A total of 31 studies involving 1558 patients were ultimately eligible for data extraction. The lowest heterogeneity was found in specificity of perfusion fraction ( f ) with the I 2 value was 17.97% and Cochran p value was 0.28. However, high heterogeneities were found for the other parameters (all I 2 > 50%). There was no publication bias found in funnel plot ( p = 0.30) for the apparent diffusion coefficient (ADC) parameter. The pooled sensitivities for ADC, f , pure diffusion coefficient ( D ), and pseudo diffusivity coefficient ( D *) were 83%, 81%, 76%, and 84%, respectively. The pooled specificities for ADC, f , D , and D * were 87%, 83%, 69%, and 81% respectively. The areas under the curves for ADC, f , D , and D * were 0.92, 0.87, 0.79, and 0.87 respectively. Conclusion Quantitative DWI and IVIM have a good diagnostic performance for differentiating malignant and benign pancreatic lesions. Key Points • IVIM has high sensitivity and specificity (84% and 83%, respectively) for differential diagnosis of pancreatic lesions, which is comparable to that of the ADC (83% and 87%, respectively). • The ADC has an excellent diagnostic performance for differentiating malignant from benign IPMNs (sensitivity, 0.83; specificity, 0.92); the f has the best diagnostic performance for differentiating pancreatic carcinoma from PNET (sensitivity, 0.85; specificity, 0.85). • For the ADC, using a maximal b value < 800 s/mm 2 has a higher diagnostic accuracy than ≥ 800 s/mm 2 ; performing in a high field strength (3.0 T) system has a higher diagnostic accuracy than a low field strength (1.5 T) for pancreatic lesions.

Value of Apparent Diffusion Coefficient for Predicting Malignancy of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Value of DWI on differentially diagnosing malignant and benign mucinous cystic neoplasms of pancreas

Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI]

Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant from Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis

Effective Apparent Diffusion Coefficient Parameters for Differentiation Between Mass-Forming Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma

Accuracy of quantitative diffusion-weighted imaging for differentiating benign and malignant pancreatic lesions: a systematic review and meta-analysis

Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm

Differentiation of Pancreas Carcinoma from Healthy Pancreas Using Diffusion-Weighted MR Imaging:Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion-Derived Parameters

Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters.

Limited Role of the Apparent Diffusion Coefficient (ADC) for Tumor Grade and Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma

Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade.

The Added Value of Intravoxel Incoherent Motion Diffusion Weighted Imaging Parameters in Differentiating High-Grade Pancreatic Neuroendocrine Neoplasms from Pancreatic Ductal Adenocarcinoma

The Value of Diffusion-Weighted Imaging in Assessing the ADC Changes of Tissues Adjacent to Breast Carcinoma

Apparent Diffusion Coefficient (ADC) Value: A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer

The value of apparent diffusion coefficient in the assessment of cervical cancer

Diagnostic Performance of Minimum Apparent Diffusion Coefficient Value in Differentiating the Invasive Breast Cancer and Ductal Carcinoma in Situ.

Evaluation of malignancy in gallbladder tumors using the apparent diffusion coefficient obtained by diffusion‑weighted MRI

ADC Mapping of Benign and Malignant Breast Tumors

Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions]

Diagnostic Value of Apparent Diffusion Coefficient Value in Prediction of Grade for Neuroepithelial Tumors

Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT